336 related articles for article (PubMed ID: 33288322)
1. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
[TBL] [Abstract][Full Text] [Related]
2. Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity.
Chahal S; Rani P; Shweta ; Goel KK; Joshi G; Singh R; Kumar P; Singh D; Sindhu J
Bioorg Chem; 2024 Jun; 147():107363. PubMed ID: 38657527
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
[TBL] [Abstract][Full Text] [Related]
5. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.
Islam MS; Ghawas HM; El-Senduny FF; Al-Majid AM; Elshaier YAMM; Badria FA; Barakat A
Bioorg Chem; 2019 Feb; 82():423-430. PubMed ID: 30508794
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of alpha amylase inhibitors based on privileged indole scaffold.
Noreen T; Taha M; Imran S; Chigurupati S; Rahim F; Selvaraj M; Ismail NH; Mohammad JI; Ullah H; Javid MT; Nawaz F; Irshad M; Ali M
Bioorg Chem; 2017 Jun; 72():248-255. PubMed ID: 28482265
[TBL] [Abstract][Full Text] [Related]
8. Spiroindolone Analogues as Potential Hypoglycemic with Dual Inhibitory Activity on α-Amylase and α-Glucosidase.
Altowyan MS; Barakat A; Al-Majid AM; Al-Ghulikah HA
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242688
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vivo antidiabetic activity of novel dispiropyrrolidines through [3+2] cycloaddition reactions with thiazolidinedione and rhodanine derivatives.
Murugan R; Anbazhagan S; Lingeshwaran ; Sriman Narayanan S
Eur J Med Chem; 2009 Aug; 44(8):3272-9. PubMed ID: 19395129
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of theophylline containing variant acetylene derivatives as α-amylase inhibitors.
Ruddarraju RR; Kiran G; Murugulla AC; Maroju R; Prasad DK; Kumar BH; Bakshi V; Reddy NS
Bioorg Chem; 2019 Nov; 92():103120. PubMed ID: 31525527
[TBL] [Abstract][Full Text] [Related]
11. Microwave-assisted rapid synthesis of spirooxindole-pyrrolizidine analogues and their activity as anti-amyloidogenic agents.
de Silva NH; Pyreddy S; Blanch EW; Hügel HM; Maniam S
Bioorg Chem; 2021 Sep; 114():105128. PubMed ID: 34225163
[TBL] [Abstract][Full Text] [Related]
12. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, α-amylase inhibitory potential and molecular docking study of indole derivatives.
Taha M; Baharudin MS; Ismail NH; Imran S; Khan MN; Rahim F; Selvaraj M; Chigurupati S; Nawaz M; Qureshi F; Vijayabalan S
Bioorg Chem; 2018 Oct; 80():36-42. PubMed ID: 29864686
[TBL] [Abstract][Full Text] [Related]
15. Trifluoromethylated Flavonoid-Based Isoxazoles as Antidiabetic and Anti-Obesity Agents: Synthesis, In Vitro
Algethami FK; Saidi I; Abdelhamid HN; Elamin MR; Abdulkhair BY; Chrouda A; Ben Jannet H
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500647
[TBL] [Abstract][Full Text] [Related]
16. Three-Component Access to Functionalized Spiropyrrolidine Heterocyclic Scaffolds and Their Cholinesterase Inhibitory Activity.
Boudriga S; Haddad S; Murugaiyah V; Askri M; Knorr M; Strohmann C; Golz C
Molecules; 2020 Apr; 25(8):. PubMed ID: 32340203
[TBL] [Abstract][Full Text] [Related]
17. A Facile One-Pot Construction of Succinimide-Fused Spiro[Pyrrolidine-2,3'-Oxindoles] via 1,3-Dipolar Cycloaddition Involving 3-Amino Oxindoles and Maleimides.
Jin L; Liang F
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510590
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
[TBL] [Abstract][Full Text] [Related]
19. 2-Aryl benzimidazoles: Synthesis, In vitro α-amylase inhibitory activity, and molecular docking study.
Adegboye AA; Khan KM; Salar U; Aboaba SA; Kanwal ; Chigurupati S; Fatima I; Taha M; Wadood A; Mohammad JI; Khan H; Perveen S
Eur J Med Chem; 2018 Apr; 150():248-260. PubMed ID: 29533872
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents.
Arumugam N; Almansour AI; Kumar RS; Siva Krishna V; Sriram D; Dege N
Bioorg Chem; 2021 May; 110():104798. PubMed ID: 33735710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
